CrossrefInfokarte
House of Lords Provides Guidance on the Law of Obviousness in Patent Actions; Increased Opportunities to Obtain Supplementary Protection Certificates for Combinations of Active Ingredients; Patent for DNA and Protein Sequence Invalid Due to Lack of Industrial Application
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector · 2008
DOI: 10.1057/jgm.2008.29 ↗Abstract
Kein Abstract verfügbar.
EUVIMED